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Background: The pathogenesis and immune response to Middle East respiratory syndrome (MERS) caused by a
recently discovered coronavirus, MERS-CoV, have not been fully characterized because a suitable animal model is
currently not available. 18F-Fluorodeoxyglucose ([18F]-FDG)-positron emission tomography/computed tomography
(PET/CT) as a longitudinal noninvasive approach can be beneficial in providing biomarkers for host immune response.
[18F]-FDG uptake is increased in activated immune cells in response to virus entry and can be localized by PET imaging.
We used [18F]-FDG-PET/CT to investigate the host response developing in nonhuman primates after MERS-CoV
exposure and applied kinetic modeling to monitor the influx rate constant (Ki) in responsive lymphoid tissue.
Methods: Multiple [18F]-FDG-PET and CT images were acquired on a PET/CT clinical scanner modified to operate in a
biosafety level 4 environment prior to and up to 29 days after MERS-CoV aerosol exposure. Time activity curves of
various lymphoid tissues were reconstructed to follow the [18F]-FDG uptake for approximately 60 min (3,600 s).
Image-derived input function was used to calculate Ki for lymphoid tissues by Patlak plot.
Results: Two-way repeated measures analysis of variance revealed alterations in Ki that was associated with the time
point (p < 0.001) after virus exposure and the location of lymphoid tissue (p = 0.0004). As revealed by a statistically
significant interaction (p < 0.0001) between these two factors, the pattern of Ki changes over time differed between
three locations but not between subjects. A distinguished pattern of statistically significant elevation in Ki was observed
in mediastinal lymph nodes (LNs) that correlated to Ki changes in axillary LNs. Changes in LNs Ki were concurrent with
elevations of monocytes in peripheral blood.
Conclusions: [18F]-FDG-PET is able to detect subtle changes in host immune response to contain a subclinical virus
infection. Full quantitative analysis is the preferred approach rather than semiquantitative analysis using standardized
uptake value for detection of the immune response to the virus.
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The pathogenesis and immune response to Middle East
respiratory syndrome (MERS) caused by a recently dis-
covered coronavirus, MERS-CoV, has not been fully
characterized, in part, because a suitable animal model
that mimics human MERS is currently not available.
Nonhuman primates (NHPs), such as rhesus monkeys
(Macaca mulatta) or common marmosets (Callithrix jac-
chus) inoculated with MERS-CoV via combined intratra-
cheal, intranasal, oral, and ocular routes, develop transient
respiratory disease with little or no viremia although lethal
disease was observed in a small number of marmosets
[1–4]. 18F-Fluorodeoxyglucose ([18F]-FDG) PET/CT as
a real-time noninvasive approach can be beneficial in
providing biomarkers for host immune response and
disease progression. [18F]-FDG-PET/CT has been used
to track host immune response during monkeypox
virus and human immunodeficiency virus-1 infections
[5–7]. As [18F]-FDG uptake is increased in activated
macrophages, lymphocytes, and granulocytes during in-
flammation, the immune response can be localized by
PET imaging [8]. Tracking the host response noninva-
sively is especially useful when animal species studied
is limited and/or expensive to obtain or when animals
do not develop overt clinical signs of disease.
We applied [18F]-FDG-PET/CT imaging to monitor
infection development in rhesus macaques after MERS-
CoV inhalation. Compared to standardized uptake value
(SUV), we increased the accuracy of measurement of
[18F]-FDG uptake by applying kinetic modeling and
Patlak graphical analysis. We assessed the net [18F]-FDG
uptake rate constant (Ki) in primary lymphoid tissues
engaged in the host response to MERS-CoV exposure.
This study is the first application of the methodology to
an acute infectious disease process.
Methods
Ethics statement
Rhesus macaques were housed in a biosafety level 4
containment facility accredited by the Association for
Assessment and Accreditation of Laboratory Animal
Care International. Experimental procedures were approved
by the National Institute of Allergy and Infectious Diseases
(NIAID), Division of Clinical Research (DCR), Animal Care
and Use Committee and were in compliance with the Ani-
mal Welfare Act regulations, Public Health Service policy,
and the Guide for the Care and Use of Laboratory Animals
recommendations.
Virus preparation
For aerosol inhalation, MERS-CoV-Hu/Jordan-N3/2012
strain (GenBank accession no. KC776174.1) [9] was grown
in Eagle’s Minimum Essential Medium (Lonza, MD, USA)
on Vero E6 cells.Aerosol challenge
Prior to aerosol challenge, four rhesus macaques, two males
and two females, 3–5 years old, weighing 3–5 kg each, were
anesthetized by intramuscular ketamine (10–15 mg/kg) in-
jection. Head-out plethysmography (Buxco-Data Sciences
International, MN, USA) was used to calculate an average
respiratory minute volume (mL/min) by multiplying the
respiration rate by the tidal volume. Aerosol concentrations
derived from a SKC biosampler (SKC Inc., PA, USA)
were used to calculate the presented dose [10]. Within
a negative-pressure (−24.9 Pa), head-only aerosol exposure
chamber, macaques were exposed to a small-particle (0.5–
3 μm aerodynamic diameter targeting lung alveoli) aerosol
challenge (inhaled dose = log10– 4.64 plaque-forming units).
Data acquisition
Imaging data were acquired with Gemini PET/CT clinical
scanner (Philips Healthcare, Andover, MA, USA) [5, 11].
With an axial field-of-view (FOV) of 180 mm of the PET
scanner, the entire NHP thorax is imaged in a single bed
position. Use of the scanner’s brain protocol resulted in a
transverse field of view of 256 mm and led to cubic 2-
mm-wide voxels in the reconstructed images. Low-dose
CT images of the thorax for PET attenuation purposes
were acquired at 120 kVp, 3-mm slice thickness, and
1.5-mm spacing. No contrast was given, and the subjects
were freely breathing during the scan. PET image acquisi-
tion was initiated immediately after the low-dose CT scans
and 1 min prior to intravenous injection of [18F]-FDG
(9–10 MBq/kg) into the saphenous vein and continued
for up to 60 min (3600 s). Nine imaging sessions per ani-
mal were conducted on pre-inoculation days −14 or −13
and −11 or −10 and post-inoculation days +1 or +2, +3
or +4, +7 or +8, +9 or +10, +15 or +16, +21 or +22, and
+28 or +29 with MERS-CoV.
Image reconstruction
SUV PET images were reconstructed iteratively using the
manufacturer supplied 3D line-of-response (LOR)-based
row-action maximum-likelihood algorithm [12]. Methods
for scatter, decay, random, and attenuation correction were
applied during the image reconstruction process. Both
scatter and attenuation corrections [13] were based on
the low-dose CT images acquired prior to the PET scans.
The list mode data were sorted into 46 dynamic frames
during creation of the histograms. To extract the early
tracer dynamic distribution in the arterial blood, the initial
data set (up to 720 s or 12 min) was comprised of 39
frames with the following time sequence: 15 frames × 2 s, 6
frames × 5 s, 5 frames × 10 s, 5 frames × 20 s, 4 frames ×
40 s, and 4 frames × 120 s. This sequence was followed by 3
frames × 240 s and 4 frames × 480 s to capture the late slow
phase of dynamic distribution of the tracer in both the
blood and the tissues. PET images were reconstructed
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maximization algorithm with two iterations and nine sub-
sets followed by 18 iterations of maximum a posteriori re-
construction [14]. Maximum a posteriori parameters were
adjusted to provide a uniform spatial resolution of 4.8 mm
(full-width half-maximum= 4.8 mm) in all three directions.
Methods for scatter, decay, random, and attenuation cor-
rection were applied during the process of PET image
reconstruction.Volume of interest definition
Reconstructed SUV PET images were analyzed without
any post-reconstruction smoothing using PMOD version
3.5 (PMOD Technologies, Zurich, CH). To extract anFig. 1 Measurement of image-derived input function. a, b SUV [18F]-FDG-P
bolus injection showing high concentrations of radiotracer in the arterial b
spheres, in the arch of aorta, sagittal view (a), and the left ventricle, corona
determined in the left ventricle (blue line) and in the arch of aorta (green lin
orange line in two animals. Inserts show SUVs from the subject and average
e Two-tissue compartment kinetic model with irreversible tracer. Ca(t) is
concentration of the tracer in extracellular space, and Cm(t) is the concentratio
fluorodeoxyglucose; VOI, volume of interestimage-derived input function (IDIF), VOI (2-mm
spheres) were placed on the left ventricles and arch of
the aorta using frames over the first 6 min (360 s)
after [18F]-FDG injection (Fig. 1a, b). Averaged data
from two VOIs were used to generate the IDIF (Fig. 1c,
d). Two-ml spheres were placed on axillary and medi-
astinal LNs and lumbar spine bone marrow as de-
scribed previously [6], and 5-mm spheres were placed
on right and left sides of the lungs to obtain the tissue
time activity curves (TACs). The last time point of the
TACs was used to generate the SUV data.
Kinetic modeling
Using the standard two-tissue compartment kinetic model
with irreversible tracer metabolism (k4 = 0, Fig. 1e), theET images reconstructed 6 min (360 s) after [18F]-FDG
lood. Black circles on the images show the location of the VOIs, 2-mm
l view (b). c, d The kinetics of [18F]-FDG SUV in the arterial blood was
e), and the average of SUVs from these two sites is shown by the
of the two sites in the first 203 s after [18F]-FDG injection.
the concentration of the tracer in arterial blood, Ce(t) is the
n of the phosphorylated [18F]-FDG in the tissue. Abbreviations: FDG,
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lung tissues [15]. The blood volume fraction (Vb) was in-
cluded in the modeling. Patlak linear regression method
was applied for parameter estimation utilizing the IDIF,
[18F]-FDG tissue TACs [16], and PMOD version 3.5
(PMOD Technologies). Tissue TACs were fitted to the
models by use of the nonlinear least-squares method with
the Levenberg-Marquardt algorithm, which minimizes the
weighted sum of squared errors between PET measure-
ment and model solutions. A plot of the ratio Ctis(t)/Cbl(t)
against the ratio of cumulative to instantaneous blood
activity concentration (“normalized time”) became lin-
ear in the late phase after the tracer injection when the
concentration of free (i.e., unmetabolized) [18F]-FDG in
the blood had equilibrated with that of free tracer in
extravascular volume of distribution. This linear part of
the plot was fitted by Eq. (1) to identify the Ki as a
slope of a regression line:
Ctis




Cbl tð Þ þ V dist ð1Þ
in which Ctis(t) and Cbl(t) represent the radioactivity
concentration in the region of interest and the arterial
blood assessed from the PET images at different time
points after an [18F]-FDG injection, respectively, and
Vdist is an initial distribution volume. A criterion for
maximum error was set to 5 % to derive the model
parameter values. For the [18F]-FDG model described in
Fig. 1, the slope equals K1 × k3 ÷ (k2 + k3).
Hematology and clinical observations
Complete blood cell counts were determined on PET-scan
days [5]. Body temperature or body weight were moni-
tored once daily or once every other day, respectively.
Statistical analysis
Two-way repeated measures analysis of variance (ANOVA)
with post hoc Bonferroni multiple comparison test used
Ki obtained pre-inoculation and post-inoculation with
MERS-CoV and VOI location as independent variables
to characterize the host immune response. For two-way
repeated measures ANOVA, we used Ki at different time
points pre-inoculation with MERS-CoV and VOI location
as within and between two factors, respectively.
The correlations between Ki values in mediastinal and
axillary LNs and bone marrow and between monocyte
fraction in the blood and mediastinal and axillary LNs
were calculated using the Pearson product moment
correlation coefficient (r). The D’Agostino and Pearson
test [17] was applied to confirm that the data followed a
Gaussian distribution. GraphPad Prizm 6.01 (GraphPadSoftware Inc., La Jolla, CA, USA) was used for all statis-
tical analyses.
Results
Host response to MERS-CoV challenge
Analysis of lung data revealed no pathology on CT images
and no changes in [18F]-FDG uptake up to day 30 after
MERS-CoV inhalation (data not shown). No changes in
body temperature, body weight, and blood glucose con-
centrations (69.9 ± 7.4 mg/dL prior to exposure and
63.9 ± 10.4 mg/dL after exposure) were observed. How-
ever, [18F]-FDG uptake as indicated by SUV increases
in mediastinal and axillary LNs post-inhalation (Fig. 2,
Additional file 1: Movie S1). Analysis of complete blood
cell counts revealed a slight increase (within normal range)
in circulating monocytes only that peaked on day 5 or 6
post-inhalation and remained elevated through the remain-
der of the study (Fig. 3a).
SUV time activity curves
Images of the first 37 time frames comprised of 2–120 s
each caught the fast kinetics of [18F]-FDG distribution in
the arterial blood (Fig. 1c, d). The rest of six time
frames, 4–8 min in duration, covered the slow distribu-
tion and accumulation of [18F]-FDG in the tissues at
later time points (16–60 min, slow phase) (Additional
file 2: Movie S2, Fig. 4). SUV TACs for axillary LNs plat-
eaued 15 min (900 s) after FDG injection and were simi-
lar throughout the study duration of 1.5 months
(Fig. 4b). Analogously, bone marrow SUV TACs did not
show significant variation during the study. However,
compared with the axillary LNs, the TACs for bone mar-
row continued to rise at 60 min (3,600 s) after [18F]-
FDG injection (Fig. 4b, c) suggesting a longer time after
[18F]-FDG injection for the tissue with high cell glycolytic
activity to reach a steady state. In mediastinal LNs, TACs
rise was pronounced on days 5–9 post-inhalation only, as
indicated by TACs (Fig. 4a).
Kinetic modeling
Representative Patlak plots for bone marrow and medi-
astinal and axillary LNs are shown in Fig. 5. Ki obtained
2 days prior to virus exposure remained unchanged for
each lymphoid tissue (Fig. 3a, b). The mean baseline Ki
prior to MERS-CoV exposure was similar in axillary and
mediastinal LNs (0.0062 ± 0.002 SD and 0.008 ± 0.004 SD,
respectively). Greater elevation in mean Ki values (up
to almost six-fold increase from pre-exposure scan) in
mediastinal LNs was observed within the first week
after MERS-CoV exposure compared to mean Ki values
(<two-fold increase from pre-exposure scan) in axillary
LNs (0.04 ± 0.01 SD and 0.01 ± 0.002 SD for mediastinal
and axillary LNs on day 5/6 post-exposure), respect-
ively, Figs. 3a, b and 6b, e). The [18F]-FDG mean Ki in
ab
Fig. 2 [18F]-FDG uptake in mediastinal (a) and axillary (b) LNs before and after MERS-CoV aerosol exposure in rhesus macaques. SUV [18F]-FDG-PET
images coregistered with CT images showed tracer uptake in two representative rhesus macaques prior to and on day 5 after MERS-CoV aerosol
exposure at 50–60 min after [18F]-FDG injection. White dashed circles show the location of the mediastinal and axillary LNs. Images are shown in coronal
view. Abbreviations: FDG, fluorodeoxyglucose; LNs, lymph nodes; MERS-CoV, Middle East respiratory syndrome-coronavirus
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higher (0.03 ± 0.006 SD) compared to that observed in the
LNs but did not follow the pattern of LN changes ob-
served after virus challenge (Fig. 3b).
Statistical analysis using two-way repeated measures
ANOVA revealed that alteration in Ki values was associ-
ated with the time point (p < 0.001) after virus exposure
and the location of lymphoid tissue (p = 0.0004). As re-
vealed by a statistically significant interaction (p < 0.0001)
between these two factors, the pattern of changes in Kiover time differed between three locations but not between
subjects. Post hoc analysis by Bonferroni’s multiple com-
parison test specified a statistically significant increase in Ki
in mediastinal LNs post-exposure compared with the Ki
values prior to virus challenge (p < 0.015, Fig. 3a). Correl-
ation between Ki changes in axillary and mediastinal LNs
was statistically significant, r = 0.758, p = 0.0179 (data
not shown). In addition, changes in [18F]-FDG uptake
as indicated by Ki in mediastinal and axillary LNs cor-




Fig. 3 Changes in [18F]-FDG uptake and monocytes fraction in the blood after MERS-CoV aerosol challenge. a Ki in mediastinal LNs (y-axis on the
left) and monocyte fraction in the blood (y-axis on the right) at different days prior to and after MERS-CoV exposure. b Ki in bone marrow and axillary
LNs at different days prior to and after MERS-CoV exposure. Each column represents mean ± SD (n = 4). Post hoc analysis by Bonferroni’s multiple
comparison test specified a statistically significant increase in Ki in mediastinal LNs up to days +15 or +16 post-exposure compared with the Ki
values prior to virus challenge (adjusted p= 0.0152 on day +3 or +4, p< 0.0001 on days +5 or +6, +7 or +8, and +9 or +10, respectively, and p= 0.0004 on
day +15 or +16). c, d Pearson product moment correlation between elevation in [18F]-FDG uptake in mediastinal (c) and axillary (d) LNs and changes in
blood monocyte fraction. Abbreviations: FDG, fluorodeoxyglucose; Ki, [
18F]-FDG uptake rate constant; LNs, lymph nodes
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p = 0.04, respectively (Fig. 3c, d).
For comparison with the results obtained with Ki, we
evaluated the host response to MERS-CoV exposure
using SUVs from 49 to 57 min (2940 to 3420 s) after
[18F]-FDG injection (Additional file 3: Fig. S1c), the
last time point from the TACs (Fig. 4a, b). The main
difference between the findings using Ki and SUVs is
that the correlations between the changes in medias-
tinal and axillary LNs (data not shown) and between
monocytes fraction and the SUVs in axillary LNs were
lost (Additional file 3: Fig. S1c). In addition, the first
pronounced increase in [18F]-FDG uptake in axillary
LN observed on day 5/6 post-exposure with Ki (Fig. 6e)
was not detected when analyzed by SUVs (Fig. 6d).
Furthermore, the magnitude of changes in axillary LNs as-
sociated with virus exposure was greater with Ki compared
with SUVs, (Fig. 6c, f ). For example, average percent
change for Ki in axillary LNs was 52.9 ± 19.4 % SD, while
an increase in [18F]-FDG uptake after MERS-CoV ex-
posure determined by SUVs was about two-fold less,
25.1 ± 13.9 % SD.Discussion
We monitored 18F-FDG uptake primarily in lymphoid
tissues at different locations in response to aerosol MERS-
CoV challenge in NHPs. A group of mediastinal LNs
showed a specific pattern of changes in Ki up to 29 days
post-virus exposure that correlates to Ki changes in ax-
illary lymph nodes. As the mediastinal LNs are the
lung-draining LNs, these LNs had the greatest increase
in Ki values compared to other lymphoid tissues. The
increase in Ki in axillary LNs was 1/3 of that observed
in mediastinal LNs and was not statistically significant.
Nevertheless, changes in Ki in axillary and mediastinal
LNs were concurrent with elevated percentage of mono-
cytes in peripheral blood.
As shown by previously published studies, LN activa-
tion during viral infection generates an [18F]-FDG signal
that can be easily discerned from background activity
[7, 18]. Activated lymphocytes increase glucose uptake
by approximately 20-fold over 24 h [19]. Moreover, results
from a few longitudinal studies in rhesus macaques
challenged with simian-human immunodeficiency virus or
humans withdrawing from antiretroviral therapy indicate
ac
b
Fig. 4 TACs of mediastinal LNs (a), axillary LNs (b), and bone marrow (c) prior to and after MERS-CoV aerosol exposure. Abbreviations: LNs, lymph
nodes; MERS-CoV, Middle East respiratory syndrome-coronavirus; TAC, time activity curves
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fulminant virus replication. Systemic factors such as
viral proteins or cytokines could be engaged in lymphoid
tissue response [7, 18]. As monocytes are part of the
immune response to virus infection (e.g., cytokine re-
lease, phagocytosis), correlation between an increase in
monocyte fraction and [18F]-FDG uptake in the LNs is
not surprising.
We compared kinetic modeling using Ki to analysis
using SUV to quantify [18F]-FDG uptake. By definition,
SUV represents the radioactivity concentration in the re-
gion of interest adjusted for the injected dose and the
body weight. Therefore, the SUV is influenced by several
parameters such as (1) body composition, (2) blood glucose
concentration, and (3) time interval from [18F]-FDG in-
jection to image acquisition. As noted in TACs of bone
marrow throughout the study and of mediastinal LNs
on days 5–9 post-exposure, SUVs did not reach a plateau
within 60 min (3600 s) after [18F]-FDG injection. Thus,
high metabolic activity of proliferating cells in bone mar-
row requires longer time for [18F]-FDG to reach steady
state in this tissue even under physiological conditions. Asthe LN biopsies have not been performed in the current
study, future studies sampling the tissue from mediastinal
LNs at peak response will be able to identify the specific
cell type associated with increase in [18F]-FDG uptake in
the LNs. Notably, by applying kinetic modeling analysis,
we were able to determine a steady state parameter
that characterizes the system based on two processes:
[18F]-FDG delivery from the blood to the tissue of interest
and the state of cell metabolic activity. As multiple time
points from PET-acquired data are used in the kinetic
modeling analysis, the accuracy of Ki computation for
small regions of interest is higher compared with SUVs
even in the presence of high noise [16]. In this study, kin-
etic modeling increases the signal-to-noise ratio resulting
in an improvement of the accuracy of measurement and
method sensitivity over analysis with SUV. If the effect is
mild, then a semiquantitative analysis by SUV will not be
able to detect it.
In this study, we attempted to develop an aerosol NHP
model of MERS-CoV infection. The current NHP aerosol
model failed to cause overt signs of MERS-CoV infection.
Comparison of our results to other MERS-CoV challenge















































Ki (slope) = 0.03
Ki (slope) = 0.025
Ki (slope) = 0.01
Fig. 5 Patlak plots generated from IDIF and TACs from mediastinal (a) and axillary (b) LNs and bone marrow (c) on day 7 after MERS-CoV exposure
in one representative animal. Green dots represent the experimental curve. Tissue [18F]-FDG net uptake rate (Ki) is calculated as a slope of computed
regression line (orange triangles and solid lines). For constant [18F]-FDG levels in arterial blood during the late phase, normalized time is identical to the
true imaging time. Abbreviations: FDG, fluorodeoxyglucose; IDIF, image-derived input function; TACs, time activity curves
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dose units and route(s) of administration. Doses given in
previous studies were expressed as tissue culture infec-
tious dose 50 % (TCID50) and was given by a combination
of intratracheal, ocular, oral, and intranasal routes [2, 3] or
by intratracheal route only [4]. Nevertheless, as [18F]-
FDG-PET quantitated the host response to virus challenge
while CT revealed no pathology on the images, the sensi-
tivity of CT for detection of host response is lower than
[18F]-FDG-PET [20]. Similarly, results from a MERS-CoV
exposure in rabbits demonstrated that MERS-CoV repli-
cates in the lung tissue without the development of overt
clinical signs [21]. As subclinical MERS-CoV infection has
been reported more often in patients without comorbidi-
ties than in patients with comorbidities [22–24], this ani-
mal model can be used to study the host response to
MERS-CoV and to test the intervention strategies aimed
at inhibition of MERS-CoV replication [21]. However,
suppression of immune responses to MERS-CoV exposure
in these animals may be needed to reflect the severity of
MERS observed in the majority of patients.
Other limitations of this feasibility study are the small
number of subjects and preexisting health status. As
this study used young, previously healthy animals with
an apparently intact immune response, translation of
these findings to older MERS patients with numerouscomorbidities should be done with caution. Since [18F]-
FDG-PET identifies the location and the pattern of host
response to virus challenge, future studies with a higher
challenge dose will investigate changes in [18F]-FDG uptake
along with results of histopathological and immunological
analysis of responsive lymphoid tissues.
[18F]-FDG is generally considered to be a nonspecific
tracer for inflammation/immune activation, and the cells
involved in the host response cannot be specified by
[18F]-FDG-PET. However depending on the virus and
the disease stage, certain populations of immune cells
will be involved in the response. Therefore, the location
and pattern of [18F]-FDG changes in the body during in-
fection progression will be virus specific. Compared with
clinical application in which [18F]-FDG-PET is mostly
used for diagnostic purposes, preclinical studies are per-
formed under controlled conditions using within subject
design. The metabolic map of the body determined prior
to virus exposure is used to identify the location of the
tissues with elevated glycolytic activity after the expos-
ure. The specific pattern of [18F]-FDG changes in the
foci identified by PET at pre- and post-exposure states
are monitored day-by-day. When the pattern and the lo-
cation of [18F]-FDG changes are identified following
virus exposure, this pattern can be used to monitor the






Fig. 6 Host response assessed by Patlak graphical analysis and semiquantitative analysis using SUV. SUVs (a) and Ki (b) in mediastinal LNs. SUVs
(d) and Ki (e) in axillary LNs. c, f Percent increase in SUV (black columns) and in Ki (grey columns) in mediastinal (c) and axillary (f) LNs was
calculated as (Ki or SUV post-exposure) − (Ki or SUV pre-exposure) ÷ (Ki or SUV pre-exposure) × 100 %
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the pattern and the location of [18F]-FDG changes in
lymphoid tissues that was distinctive from that observed
after MERS-CoV exposure. In addition, we were able to de-
scribe the difference between surviving and non-surviving
animals that was detected at early stages of monkeypox in-
fection. Further ongoing studies of the analysis of biopsied
tissue samples from the locations identified by PET should
be able to shed some light on specific mechanisms associ-
ated with [18F]-FDG changes after virus exposure.
Conclusions
This study extends the use of kinetic modeling of [18F]-
FDG uptake during lung inflammation to host immune
response after MERS-CoV exposure in rhesus macaques.
Compared with SUVs, Ki computation increases signal-
to-noise ratio of PET data that results in improvedaccuracy of measurement and method sensitivity. With
application of kinetic modeling of [18F]-FDG uptake in
infected animals, researchers will be able to pinpoint sites
of immune response and quantify anti-inflammatory ef-
fects of potential antiviral treatments.
Statement on welfare of animals
Rhesus macaques were housed in a biosafety level 4
containment facility accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care
International. Experimental procedures were approved by
the National Institute of Allergy and Infectious Diseases
(NIAID), Division of Clinical Research (DCR), Animal
Care and Use Committee and were in compliance with
the Animal Welfare Act regulations, Public Health Service
policy, and the Guide for the Care and Use of Laboratory
Animals recommendations.
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Additional file 1: Movie S1. Maximum intensity projection movie
showing maximal [18F]-FDG uptake in mediastinal LNs in 3-D in one
representative animal on day 5 after MERS-CoV exposure. Abbreviations:
FDG, fluorodeoxyglucose; LNs, lymph nodes; MERS-CoV, Middle East
respiratory syndrome-coronavirus. (MP4 707 kb)
Additional file 2: Movie S2. Distribution and clearance of [18F]-FDG
in the body measured via SUV. Dynamic images were taken over
60 min after [18F]-FDG injection on day 5 after MERS-CoV exposure in
one representative animal. Each image in a series represents
a sum of [18F]-FDG concentrations in three compartments defined by a
two-tissue compartment model. The first 37 images demonstrate the early
fast [18F]-FDG distribution and clearance from the blood, while the
next 7 images capture the late slow phase of dynamic [18F]-FDG
distribution in the blood and accumulation of [18F]-FDG-6-P in the
mediastinal LNs. Abbreviations: FDG-6-P, fluorodeoxyglucose-6-phosphate;
LNs, lymph nodes; MERS-CoV, Middle East respiratory syndrome-coronavirus.
(MP4 837 kb)
Additional file 3: Figure S1. Changes in [18F]-FDG uptake and
monocytes fraction in the blood after MERS-CoV aerosol challenge. (a)
SUVs in mediastinal LNs (y-axis on the left) and monocyte fraction in the
blood (y-axis on the right) at different days prior to and after MERS-CoV
exposure. Each column represents mean ± SD (n = 4). (b) SUVs in bone
marrow and axillary LNs on different days prior to and after MERS-CoV
exposure. Post hoc analysis by Bonferroni’s multiple comparison test
specified a statistically significant increase in SUV in mediastinal LNs up to
days +14 or +15 post-exposure compared with the SUVs prior to virus
challenge (adjusted p = 0.0006 on day +3 or +4, p < 0.0001 on days +5
or +6, +7 or +8, +9 or +10, and +15 or +16 respectively). (c, d) Pearson
product moment correlation between elevation in [18F]-FDG uptake in
mediastinal (c) and axillary (d) LNs determined by SUV and changes in
blood monocyte fraction. Note that the correlation between SUV in axillary
LNs and monocyte fraction lost statistical significance. Abbreviations: FDG,
fluorodeoxyglucose; Ki, [
18F]-FDG uptake rate constant; LNs, lymph nodes.
(PDF 206 kb)
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